Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(25.0%)
N/A
1(25.0%)
Phase 2
1(25.0%)
Phase 3
1(25.0%)
4Total
Phase 4(1)
N/A(1)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01601366Phase 2Completed

LNG-IUS for Treatment of Dysmenorrhea

Role: lead

NCT01608347Phase 4Completed

Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies

Role: lead

NCT02690129Not ApplicableUnknown

Vaginal Progesterone for Treatment of Threatened Miscarriage

Role: lead

NCT01254799Phase 3Completed

Doxycycline in Treatment of Bleeding With Depot Medroxyprogesterone Acetate (DMPA)

Role: lead

All 4 trials loaded